Interaction Between the Coagulation and Complement System

Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 632)

Abstract

The complement system as a main column of innate immunity and the coagulation system as a main column in hemostasis undergo massive activation early after injury. Interactions between the two cascades have often been proposed but the precise molecular pathways of this interplay are still in the dark. To elucidate the mechanisms involved, the effects of various coagulation factors on complement activation and generation of anaphylatoxins were investigated and summarized in the light of the latest literature. Own in vitro findings suggest, that the coagulation factors FXa, FXIa and plasmin may cleave both C5 and C3, and robustly generate C5a and C3a (as detected by immunoblotting and ELISA). The produced anaphylatoxins were found to be biologically active as shown by a dose-dependent chemotactic response of neutrophils and HMC-1 cells, respectively. Thrombin did not only cleave C5 (Huber-Lang et al. 2006) but also in vitro-generated C3a when incubated with native C3. The plasmin-induced cleavage activity could be dose-dependently blocked by the serine protease inhibitor aprotinin and leupeptine. Theese findings suggest, that various serine proteases belonging to the coagulation system are able to activate the complement cascade independently of the established pathways. Moreover, functional C5a and C3a are generated, both of which are known to be crucially involved in the inflammatory response.

Notes

Acknowledgement

We thank Sonja Albers and Barbara Acker for outstanding laboratory assistance. This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG HU 823/2-2, HU 823/2-3, European Shock Society/Novo Nordisk Grant 2005) and NIH AI068730.

References

  1. Bernard, G.R., Vincent, J.L., Laterre, P.F., LaRosa, S.P., Dhainaut, J.F., Lopez-Rodriguez, A., Steingrub, J.S., Garber, G.E., Helterbrand, J.D., Ely, E.W., Fisher, C.J. (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344, 699–709PubMedCrossRefGoogle Scholar
  2. Campbell, W., Okada, N., Okada, H. (2001) Caboxypeptidase R is an inactivator of complement-derived inflammatory peptides and an inhibitor of fibrinolysis. Immunol Rev 180, 162–167PubMedCrossRefGoogle Scholar
  3. Choi, G., Schultz, M.J., Levi, M., van der Poll, T. (2006) The relationship between inflammation and the coagulation system. Swiss Med Wkly 136, 139–144PubMedGoogle Scholar
  4. Davis, A.E. III. (2004) Biological effects of C1 inhibitor. Drug News Pespect 17, 439–446CrossRefGoogle Scholar
  5. Fruchterman, T.M., Spain, D.A., Wilson, M.A., Harris, P.D., Garrison, R.N. (1998) Complement inhibition prevents gut ischemia and endothelial cell dysfunction after hemorrhage/resuscitation. Surgery 124, 782–791PubMedCrossRefGoogle Scholar
  6. Ganter, M.T., Brohi, K., Cohen, M.J., Shaffer, L.A., Walsh, M.C., Stahl, G.L., Pittet, J.F. (2007) Role of the alternative pathway in the early complement activation following major trauma. Shock 28, 29–34PubMedCrossRefGoogle Scholar
  7. Hierholzer, C., Billiar, T.R. (2001) Molecular mechanisms in the early phase of hemorrhagic shock. Langenbecks Arch Surg. 386, 302–308PubMedCrossRefGoogle Scholar
  8. Hecke, F., Schmidt, U., Kola, A., Bautsch, W., Klos, A., Kohl, J. (1997) Circulating complement proteins in multiple trauma patients – correlation with injury severity, development of sepsis, and outcome. Crit Care Med 25, 2015–2024PubMedCrossRefGoogle Scholar
  9. Huber-Lang, M., Younkin, EM, Sarma, V.J., Riedemann, N., McGuire, S.R., Lu, K.T., Kunkel, R., Younger, J.G., Zetoune, F.S., Ward, P.A. (2002) Generation of C5a by phagocytic cells. Am J Pathol 161, 1849–1859PubMedCrossRefGoogle Scholar
  10. Huber-Lang, M., Sarma, J.V., Zetoune, F.S., Rittirsch, D., Neff, T.A., McGuire, S.R., Lambris, J.D., Warner, R.L., Flierl, M.A., Hoesel, L.M., Gebhard, F., Younger, J.G., Drouin, S.M., Wetsel, R.A., Ward, P.A. (2006) Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med 12, 682–687PubMedCrossRefGoogle Scholar
  11. Ikeda, K., Nagasawa, K., Horiuchi, T., Tsuru, T., Nishizaka, H., Niho, Y. (1997) C5a induces tissue factor activity on endothelial cells. Thromb Haemost 77, 394–398PubMedGoogle Scholar
  12. Jansen, P.M., Eisele, B., de Jong, I.W., Chang, A., Delvos, U., Taylor, F.B. Jr, Hack, C.E. (1998) Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock. J Immunol 160, 475–484PubMedGoogle Scholar
  13. Kaplan, A.P., Ghebrehiwet, B., Silverberg, M., Sealey, J.E. (1981) The intrinsic coagulationn-kinin pathway, complement cascades, plasma renin-angiotensin system, and their interrelationships. Crit Rev Immunol 3, 75–93PubMedGoogle Scholar
  14. Lambris, : , J.D., Sahu, A., Wetsel, R. (1998) The chemistry and biology of C3, C4, and C5. InVolanakis, J.E., Frank, M. (eds.). The Human Complement System in Health and DiseaseMarcel Dekker, New York, pp. 83–118Google Scholar
  15. Lampl, L., Helm, M., Specht, A., Bock, K.H., Hartel, W., Seifried, E. (1994) Blood coagulation parameters as prognostic factors in multiple trauma: can clinical values be an early diagnostic aid? Zentralblatt für Chirurgie 119, 683–689PubMedGoogle Scholar
  16. Levi, M., van der Poll, T., Büller, H.B. (2004) Relation between inflammation and coagulation. Circulation 109, 2698–704PubMedCrossRefGoogle Scholar
  17. Lidington, E.A., Haskard, D.O., Mason, J.C. (2000) Induction of decay-accelerating factor by thrombin through a protease-activated receptor 1 and protein kinase C-dependent pathway protects vascular endothelial cells from complement-mediated injury. Blood 96, 2784–2792PubMedGoogle Scholar
  18. Rezende, S.M., Simmonds, R.E., Lane, D.A. (2004) Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S-C4b binding protein complex. Blood 103, 1192–1201PubMedCrossRefGoogle Scholar
  19. Ritis, K., Doumas, M., Mastellos, D., Micheli, A., Giaglis, S., Magotti, P., Rafail, S., Kartalis, G., Sideras, P., Lambris, J.D. (2006) A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways. J Immunol 177, 4794–4802PubMedGoogle Scholar
  20. Spain, D.A., Fruchtermann, T.M., Matheson, P.J., Wilson, M.A., Martin, A.W., Garrison, R.N. (1999) Complement activation mediates intestinal injury after resuscitation from hemorrhagic shock. J Trauma 46, 224–233PubMedCrossRefGoogle Scholar
  21. Weiler, J.M., Linhardt, R.J. (1991) Antithrombin III regulates complement activity in vitro. J Immunol 146, 3889–3894PubMedGoogle Scholar
  22. Wojta, J., Huber, K., Valent, P. (2004) New aspects in thrombotic research: complement induced switch in mast cells from a profibrinolytic to a prothrombotic phenotype. Pathophysiol Haemost Thromb 33, 438–441CrossRefGoogle Scholar
  23. Younger, J.G., Sasaki, N., Waite, M.D., Murray, H.N., Saleh, E.F., Ravage, Z.A., Hirschl, R.B., Ward, P.A., Till, G.O. (2001) Detrimental effects of complement activation in hemorrhagic shock. J Appl Physiol 90, 441–446PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  1. 1.Department of Traumatology, Hand-, Plastic-, and Reconstructive SurgeryUniversity Hospital of UlmUlmGermany
  2. 2.Division of Experimental SurgeryUniversity Hospital of UlmUlmGermany
  3. 3.Department of Medical MicrobiologyMedical School HannoverHannoverGermany
  4. 4.Department of PathologyUniversity of PennsylvaniaPhiladelphiaUSA

Personalised recommendations